Zeyad Ibrahim Clinical Oncology Society of Australia Annual Scientific Meeting 2019

Zeyad Ibrahim

Abstracts this author is presenting:

• Novel human cancer cell-line genomic model using CRISPR/Cas9 for assessing methotrexate pharmacogenomics: MiSSK Study – Phase I — Poster Session 1
• Systematic review (SR) of methotrexate pharmacogenomics in the treatment of paediatric cancers: Evidence and Gap — Poster Session 1